Stockholm, October 14, 2020 - The Disciplinary Committee of Nasdaq Stockholm has found that Oasmia Pharmaceutical AB ("Oasmia Pharmaceutical" or the "Company") has breached the rules of Nasdaq Stockholm (the "Rulebook") and therefore ordered the Company to pay a fine of fifteen annual fees, corresponding to an amount of SEK 3,075,000. The Disciplinary Committee concludes that the Swedish Securities Council in its ruling 2019:13 has found that Oasmia Pharmaceutical has breached good practice in the stock market by not having complied with a main shareholder's request for an extraordinary general meeting for the election of board members and, when eventually convened, also having cancelled such a meeting at a late stage. The Disciplinary Committee further concludes that the Company has breached good practice in the stock market by having expressed remarks on the main shareholder's request and proposals for board members in several press releases. With reference to the above, the Disciplinary Committee concludes that Oasmia Pharmaceutical flagrantly and repeatedly has violated good practice in the stock market and, consequently, also the Rulebook. . The Disciplinary Committee takes a particularly serious view of the Company's behavior, which have been likely to damage the public's confidence in Nasdaq Stockholm and the stock market. The Disciplinary Committee's decision is available at: https://www.nasdaq.com/solutions/decisions-sanctions-stockholm-2020 About the Disciplinary Committee The role of Nasdaq Stockholm's Disciplinary Committee is to consider suspicions regarding whether Exchange Members or listed companies have breached the rules and regulations applying on the Exchange. If the Exchange suspects that a member or company has acted in breach of the rules, the matter is referred to the Disciplinary Committee. Nasdaq Stockholm investigates the suspicions and pursues the matter and the Disciplinary Committee issues a ruling regarding possible sanctions. The sanctions possible for listed companies are a warning, a fine or delisting. The fines that may be imposed range from one to 15 annual fees. The sanctions possible for Exchange Members are a warning, a fine or debarment. Fines paid are not included in the Exchange's business but are attributed to a foundation supporting research in the securities market. The Disciplinary Committee's Chairman and Deputy Chairman must be lawyers with experience of serving as judges. At least two of the other members of the Committee must have in-depth insight into the workings of the securities market. Members: Former Supreme Court Justice Marianne Lundius (Chairman), Supreme Court Justice AnnChristine Lindeblad (Deputy Chairman), Company Director Joakim Strid, Company Director Stefan Erneholm, Company Director Anders Oscarsson, Lawyer Wilhelm Lüning, Company Director Jack Junel, MBA Ragnar Boman, MBA Carl Johan Högbom, Lawyer Patrik Marcelius, Authorized Public Accountant Magnus Svensson Henryson and Former Authorized Public Accountant Svante Forsberg. About Nasdaq Nasdaq (Nasdaq: NDAQ) is a global technology company serving the capital markets and other industries. Our diverse offering of data, analytics, software and services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on Twitter @Nasdaq, or at www.nasdaq.com. Nasdaq Media Contact David Augustsson +46 (8) 4056135 david.augustsson@nasdaq.com
© 2020 GlobeNewswire